[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Pharmaceutical Companies, brings together companies in the pharmaceutical industry sector in France. Created more than 130 years ago, Leem today has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in more than 150 professions, and has recruited 10,000 employees per year for 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its R&D centers, …

Sectors: Startup accelerator & VC

[Automatic translation follows] Accelerate the growth of your startup from the innovation base camp in Auvergne #startup #lebivouac Le Bivouac by Clermont Auvergne Innovation supports startups in their growth and acceleration phases. Our network of partners, our expertise, our team, the startups we support and the innovation ecosystem around us are fundamental assets in your success. Startup accelerator with a strong digital component

Sectors: Startup accelerator & VC

From Earth to Life Limagrain is a global company with deep local roots. Our parent company is an agricultural cooperative based in the Limagne-Val d’Allier plain, in the heart of Central France’s Auvergne region, while we are an international seed and agri-food group with some 9,500 employees working in 53 countries. At Limagrain, we breed, produce, and sell high value-added field and vegetable seeds, drawing on our long history of expertise in plant improvement. Uniquely, we also have agri-food chain businesses, in France and internationally, to transform the produce of the Cooperative’s 1,300 farmer members. The world faces escalating climatic, …

Sectors: Food

[Automatic translation follows] 1st pain research foundation in France A major public health problem, chronic pain today affects 1 in 5 adults, or more than 12 million French people. And as the therapeutic arsenal is both aging and insufficient, nearly 2 thirds of patients believe that their pain is insufficiently controlled. Pain also has a very significant impact on health at work. Back pain is the leading cause of disability in the world and musculoskeletal disorders represent the leading cause of occupational illness in France. Pain alone impacts 88 million working days per year in France. Fighting pain is therefore …

Sectors: Research

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

We aspire to be the premier research-intensive biopharmaceutical company. At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of …

Sectors: Pharmaceutical